Liminatus Pharma, Inc. (LIMN)
0.242
+0.01
(+2.63%)
USD |
NASDAQ |
Mar 17, 14:10
Liminatus Pharma Price : 0.242 for March 17, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CDT Equity, Inc. | 0.4916 |
| LENZ Therapeutics, Inc. | 12.48 |
| Oruka Therapeutics, Inc. | 41.74 |
| Maze Therapeutics, Inc. | 52.58 |
| MapLight Therapeutics, Inc. | 18.16 |
Price Related Metrics
| PEG Ratio | -0.0380 |
| Earnings Yield | -76.57% |
| Market Cap | 6.550M |
| PEGY Ratio | -0.0380 |